Big Move For Calithera Biosciences, Inc.

Mon, Sep 16, 2024 at 05:30 PM

Calithera Biosciences, Inc. (CALA:NASDAQ) rocketted at $0.05, representing a gain of 212.5%. From Fri, Aug 30, 2024, the stock recorded 22.22% Up Days and 20.00% Green Days

About Calithera Biosciences, Inc. (CALA:NASDAQ)

Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

Top 10 Gainers:

Calithera Biosciences, Inc. (CALA:NASDAQ), 212.5%
NuCana plc (NCNA:NASDAQ), 150.79%
Kubient Inc. (KBNT:NASDAQ), 100%
NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
Dermata Therapeutics Inc. (DRMA:NASDAQ), 46.84%
REE Automotive Ltd. (REE:NASDAQ), 44.19%
Immuneering Corporation (IMRX:NASDAQ), 42.08%
MKDWELL Tech Inc. (MKDW:NASDAQ), 36.75%
Coffee Holding Co., Inc. (JVA:NASDAQ), 35.94%
Li-Cycle Holdings Corp. (LICY:NYSE), 34.21%